Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis - results of the placebo-controlled, double-blind, Phase III ORATORIO study - Concepedia

Concepedia

Publication | Closed Access

Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis - results of the placebo-controlled, double-blind, Phase III ORATORIO study

49

Citations

0

References

2015

Year

Xavier Montalbán, Bernhard Hemmer, Kottil Rammohan, Gavin Giovannoni, J. de Sèze, Amit Bar‐Or, Douglas L. Arnold, Annette Sauter, Algirdas Kakarieka, Donna Masterman,

mediaTUM (Technical University of Munich)

MedicineClinical NeurologyClinical TrialsNeurological ProgressNeurologyMultiple SclerosisNeuroimmunology

No additional data available for this publication yet. Check back later!